Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clopidogrel After Coronary Stenting.

Berger1

  • 1Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA.

Current Interventional Cardiology Reports
|November 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

True lupus found in a seven and a half year old girl.

Revue medicale de Nancy·2010
Same author

About a case of palmoplantar hyperhidrosis treated surgically, result dating from five years.

Memoires. Academie de chirurgie (France)·2010
Same author

Vaccine improves memory in "Alzheimer's" mice.

BMJ (Clinical research ed.)·2001
Same author

Study of B Decays to Charmonium States: B-->eta(c)K and B --> chi(c0)K.

Physical review letters·2001
Same author

Gut cells engineered to produce insulin

BMJ (Clinical research ed.)·2000
Same author

Statins could be useful in organ transplantation

BMJ (Clinical research ed.)·2000

Clopidogrel is a safer and faster-acting alternative to ticlopidine for preventing stent thrombosis after stent placement. While effective, ticlopidine has serious side effects, unlike clopidogrel.

Area of Science:

  • Cardiology
  • Pharmacology
  • Interventional Cardiology

Background:

  • Aspirin and ticlopidine are effective in preventing post-stent thrombosis.
  • Ticlopidine has significant side effects and a slow onset of action.

Purpose of the Study:

  • To compare the efficacy and safety of clopidogrel with ticlopidine for preventing stent thrombosis.
  • To evaluate clopidogrel as an alternative antiplatelet therapy after stent placement.

Main Methods:

  • Review of randomized trials and observational data comparing antiplatelet therapies.
  • Analysis of efficacy in preventing thrombosis and ischemic complications.
  • Assessment of side effect profiles and onset of action.

Main Results:

Related Experiment Videos

  • Clopidogrel demonstrates comparable efficacy to ticlopidine in preventing stent thrombosis.
  • Clopidogrel offers a superior safety profile with fewer adverse events compared to ticlopidine.
  • Clopidogrel provides a faster onset of action, particularly with large loading doses.

Conclusions:

  • Clopidogrel is a well-tolerated and effective alternative to ticlopidine for antiplatelet therapy post-stent placement.
  • Further research is needed to determine optimal clopidogrel loading doses and therapy duration.